Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

954 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
Detjen KM, Rieke S, Deters A, Schulz P, Rexin A, Vollmer S, Hauff P, Wiedenmann B, Pavel M, Scholz A. Detjen KM, et al. Among authors: schulz p. Clin Cancer Res. 2010 Jan 15;16(2):420-9. doi: 10.1158/1078-0432.CCR-09-1924. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068079
Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer.
Schulz P, Fischer C, Detjen KM, Rieke S, Hilfenhaus G, von Marschall Z, Böhmig M, Koch I, Kehrberger J, Hauff P, Thierauch KH, Alves F, Wiedenmann B, Scholz A. Schulz P, et al. FASEB J. 2011 Oct;25(10):3325-35. doi: 10.1096/fj.11-182287. Epub 2011 Jun 17. FASEB J. 2011. PMID: 21685330
An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
Stelter L, Amthauer H, Rexin A, Pinkernelle J, Schulz P, Michel R, Denecke T, Stiepani H, Hamm B, Wiedenmann B, Scholz A. Stelter L, et al. Among authors: schulz p. Neuroendocrinology. 2008;87(4):233-42. doi: 10.1159/000111502. Epub 2007 Nov 16. Neuroendocrinology. 2008. PMID: 18025811
Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
Aleku M, Schulz P, Keil O, Santel A, Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Röder N, Löffler K, Lange C, Fechtner M, Möpert K, Fisch G, Dames S, Arnold W, Jochims K, Giese K, Wiedenmann B, Scholz A, Kaufmann J. Aleku M, et al. Among authors: schulz p. Cancer Res. 2008 Dec 1;68(23):9788-98. doi: 10.1158/0008-5472.CAN-08-2428. Cancer Res. 2008. PMID: 19047158
954 results